LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5α-reductase, and produces prostatic regression in male rats-Reference-Cited by-同舟云学术

LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5α-reductase, and produces prostatic regression in male rats

Published:1993 Issue:3 Volume:23 Page:181-199
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Neubauer Blake Lee,Best Kevin L.,Blohm Thomas R.,Gates Cynthia,Goode Robin L.,Hirsch Kenneth S.,Laughlin Marie E.,Petrow Vladimir,Smalstig E. Barry,Stamm Nancy B.,Toomey Richard E.,Hoover Dennis M.

Publisher

Wiley

Subject

Urology,Oncology

Reference35 articles.

1. Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne

2. The Conversion of Testosterone to 5α-Androstan-17β-ol-3-one by Rat Prostate in Vivo and in Vitro

3. : Human benign prostatic hyperplasia: Etiological considerations. In “ Progress in Clinical And Biological Research.” , (eds): New York: Alan R. Liss, 1984, pp 1–25.

4. Transformation of Testosterone into 17β-Hydroxy-5α-androstan-3-one by Microsomal Preparations of Human Skin

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testicular Steroid Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Testicular Steroid Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2015

3. The Renaissance of CYP17 Inhibitors for the Treatment of Prostate Cancer;Cancer Drug Design and Discovery;2014

4. CYP17 Inhibitors for Prostate Cancer Treatment – An Update;Current Medicinal Chemistry;2008-04-01

5. Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development;Recent Patents on Anti-Cancer Drug Discovery;2007-01-01